Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2017;21(10):1299-1306.
doi: 10.1007/s12603-017-0884-5.

Therapeutic Role of Punica Granatum (Pomegranate) Seed Oil Extract on Bone Turnover and Resorption Induced in Ovariectomized Rats

N Z Shaban  1 , I M Talaat, F H Elrashidy, A Y Hegazy, A S Sultan
Affiliations

Therapeutic Role of Punica Granatum (Pomegranate) Seed Oil Extract on Bone Turnover and Resorption Induced in Ovariectomized Rats

N Z Shaban et al. J Nutr Health Aging. 2017.

Abstract

Context: Postmenopausal osteoporosis is mostly caused by increased bone remodeling resulting from estrogen deficiency. Hormone replacement therapy (HRT) is used to prevent osteoporosis, but it increases the risk for breast cancer, thromboembolism, strokes, and heart attacks. Pomegranate seed oil extract (SOE) is rich in phytoestrogen and antioxidant compounds.

Objectives: To evaluate the therapeutic role of SOE against bone turnover, resorption and osteoporosis induced in ovariectomized rats as a postmenopausal model and comparing the results with those from Generic CycloProgynova drug (D).

Design: The study used western albino rats undergo bilaterally ovariectomization as a model for postmenopausal.

Setting: The study took part in a laboratory setting.

Animals: Forty female western albino rats (age: 3-4 months) weighing 150-180 gm.

Measurements: Rats were divided into four groups, 10 rats each; SC-group: Sham control = untreated and unovariectomized rats; OVX-group = ovariectomized rats; (OVX-SOE) and (OVX-D) groups = OVX rats were treated with SOE and D, respectively. Bone markers (BMs) especially osteocalcin (BGP), alkaline phosphatase (ALP), tartarate resistance acid phosphatase (TRAcP), bone weight, bone calcium concentration, serum electrolytes (calcium, sodium and potassium) and serum estradiol (E2) level and histopathological examination of bones were determined. Also lipid profile, uric acid, prothrombin time (INR) and liver and kidney functions were measured to evaluate the adverse effects of SOE and D.

Results: In OVX group the activities of ALP and TRAcP and the levels of BGP, serum calcium, sodium and body weight were significantly higher (p≤0.05) than SC-group, while bone calcium concentration, bone mass, serum E2 and potassium level as well as uterus mass were significantly lower (p≤0.05). Also histopathological results revealed that the outer cortical bone became thinner, while the cancellous bone trabeculae lost their normal architecture. Moreover in OVX group lipid profile and uric acid levels were significantly higher (p≤0.05) than SC group, but there were no significant changes (p≤0.05) in INR level, liver and kidney functions. Treatment of OVX rats with SOE or D for 12 weeks improved both the architecture of bones as shown from the histopathological results and BMs, serum electrolytes and E2 levels (p≤0.05) which approached SC-group. Moreover after treatment of OVX rats with SOE the levels of lipid profile and uric acid were improved and approached SC-group, while liver function became significant lower (p≤0.05) than SC-group. Also there were no significant changes (p≤0.05) in kidney functions and INR of (OVX-SOE), OVX and SC groups. In contrast in (OVX-D) group the levels of lipid profile, liver and kidney functions, uric acid and INR were significantly higher (p≤0.05) than those of OVX and SC groups.

Conclusion: The results of this study show that SOE has therapeutic effects on osteoporosis, while it has no adverse effects on lipid profile, uric acid, liver and kidney functions when compared to HRT. SOE offers a promising alternative in the design of new strategies in nutritional management of age-related bone complications.

Keywords: Bone marker; antioxidants; osteoporosis; phytoestrogen; pomegranate seed oil extract.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest

Figures

Figure 1
Figure 1
Effect of treatment with SOE and drug D on the levels of bone markers, serum esteradiol and uterus mass in ovariectomized rats
Figure 2
Figure 2
Effect of treatment with SOE and drug D on serum electrolytes levels in ovariectomized rats
Figure 3
Figure 3
Histopathological examination of sections of tibia of sham control rats and OVX rats without and with treatments with SOE and drug D
See this image and copyright information in PMC

References

    1. Ferrari S, Bianchi ML, Eisman JA, Foldes AJ, Adami S, Wahl DA, Stepan JJ, de Vernejoul MC, Kaufman JM. OP in young adults: pathophysiology, diagnosis, and management. Osteoporos Int. 2012;23:2735–2748. 10.1007/s00198-012-2030-x PubMed PMID: 22684497. - DOI - PubMed
    1. Wang H, Liu C. Association of MTHFR C667T polymorphism with BMD and fracture risk: an updated meta-analysis. Osteoporos Int. 2012;23:2625–2634. 10.1007/s00198-011-1885-6 PubMed PMID: 22187009. - DOI - PubMed
    1. Lee HR, Kim TH, Choi KC. Functions and physiological roles of two types of estrogen receptors, ERα and ERβ, identified by estrogen receptor knockout mouse. Lab Anim Res. 2012;28:71–76. 10.5625/lar.2012.28.2.71 PubMed PMID: 22787479; PMCID 3389841. - DOI - PMC - PubMed
    1. Seibel MJ. Biochemical markers of bone turnover part I: Biochemistry and Variability. Clin Biochem Rev. 2005;26:97–122. PubMed PMID: 16648882; PMCID 1320175. - PMC - PubMed
    1. Gapstur SM, Morrow M, Sellers TA. Hormone replacement therapy and risk of breast cancer with a favorable histology: results of the Iowa Women's Health Study. JAMA. 1999;281(22):2091–2097. 10.1001/jama.281.22.2091 PubMed PMID: 10367819. - DOI - PubMed

MeSH terms

LinkOut - more resources